Cargando…
Therapeutic drug monitoring : newer drugs and biomarkers /
Therapeutic Drug Monitoring: Newer Drugs and Biomarkers features timely topics such as the monitoring of classical and newer drugs, pharmacogenomics and the application of biomarkers in therapeutic drug monitoring. This reference also discusses the limitations of current commercially available immun...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London :
AcademicElsevier Science,
2012.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn795120450 | ||
| 003 | OCoLC | ||
| 005 | 20231117044724.0 | ||
| 006 | m o d | ||
| 007 | cr un|---uuuuu | ||
| 008 | 120611s2012 enka ob 001 0 eng d | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d OCLCQ |d OPELS |d N$T |d CUX |d YDXCP |d CUS |d OCLCQ |d UKMGB |d CHVBK |d BUF |d OCLCF |d TEFOD |d OPELS |d GWM |d OCLCQ |d UAB |d CDX |d UKDOC |d TEFOD |d OCLCQ |d OPELS |d OCLCQ |d OPELS |d CASUM |d OCLCO |d LEATE |d OCLCO |d OCLCA |d KIJ |d U3W |d D6H |d OCLCO |d AU@ |d OCLCO |d WYU |d OCLCO |d LEAUB |d OCLCO |d OCLCQ |d OCLCA |d OCLCQ |d U3G |d OCLCA |d S2H |d OCLCO |d TUHNV |d OCLCO |d OCLCQ |d OCLCO | ||
| 016 | 7 | |a 016098398 |2 Uk | |
| 019 | |a 799893318 |a 1087380982 | ||
| 020 | |a 9780123854681 |q (electronic bk.) | ||
| 020 | |a 0123854687 |q (electronic bk.) | ||
| 020 | |z 9780123854674 |q (p-ISBN) | ||
| 020 | |z 0123854679 |q (p-ISBN) | ||
| 035 | |a (OCoLC)795120450 |z (OCoLC)799893318 |z (OCoLC)1087380982 | ||
| 050 | 4 | |a RM301.9 | |
| 060 | |a WB 330 |b T547 2012eb | ||
| 072 | 7 | |a MED |x 012000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.5/8 |a 615.58 |
| 245 | 0 | 0 | |a Therapeutic drug monitoring : |b newer drugs and biomarkers / |c edited by Amitava Dasgupta. |
| 260 | |a London : |b AcademicElsevier Science, |c 2012. | ||
| 300 | |a 1 online resource (vii, 459 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | 0 | |a Online resource; title from pdf title page (viewed July 10, 2012). | |
| 505 | 0 | |a Front matter -- Copyright -- Contributers -- Chapter 1. Introduction to therapeutic drug monitoring: frequently and less frequently monitored drugs -- Chapter 2. Effects of pre-analytical variables in therapeutic drug monitoring -- Chapter 3. Analytical techniques used in therapeutic drug monitoring -- Chapter 4. Clinical utility of free drug monitoring -- Chapter 5. Current practice of therapeutic drug monitoring: dose adjustment of drugs using pharmacokinetic models -- Chapter 6. An introduction to personalized medicine -- Chapter 7. Application of ultra-high throughput sequencing and microarray technologies in pharmacogenomics testing -- Chapter 8. Pharmacogenomics and Warfarin therapy -- Chapter 9. Applications of pharmacokinetic and pharmacodynamic principles to optimize drug dosage selection: example of antibiotic therapy management -- Chapter 10. Guidelines for the monitoring of vancomycin, aminoglycosides and certain antibiotics -- Chapter 11. Challenges in therapeutic drug monitoring of digoxin and other anti-arrhythmic drugs -- Chapter 12. Therapeutic drug monitoring of classical and newer anticonvulsants -- Chapter 13. Challenges in therapeutic drug monitoring of classical tricyclic and newer antidepressants: analytical and pharmacogenetics considerations -- Chapter 14. Therapeutic drug monitoring of selected anticancer drugs: pharmacogenomics issues -- Chapter 15. Immunosuppressive drug monitoring: limitations of immunoassays and the application of liquid chromatography mass spectrometry -- Chapter 16. Biomarkers: the link between therapeutic drug monitoring and pharmacodynamics of immunosuppressants -- Chapter 17. Therapeutic drug monitoring of antiretroviral drugs in the management of human immunodeficiency virus infection -- Chapter 18. Drug testing in pain management -- Chapter 19. Effect of herbal supplement-drug interactions on therapeutic drug monitoring -- Index. | |
| 520 | |a Therapeutic Drug Monitoring: Newer Drugs and Biomarkers features timely topics such as the monitoring of classical and newer drugs, pharmacogenomics and the application of biomarkers in therapeutic drug monitoring. This reference also discusses the limitations of current commercially available immunoassays for therapeutic monitoring. It presents�new and sophisticated techniques used for proper determination of blood levels and the clinical utility of therapeutic drug monitoring of contemporary drugs. Written by leading international experts and geared toward clinical pathol. | ||
| 650 | 0 | |a Drug monitoring. | |
| 650 | 0 | |a Chemotherapy. | |
| 650 | 0 | |a Biochemical markers. | |
| 650 | 0 | |a Biological monitoring. | |
| 650 | 0 | |a Drugs |x Analysis. | |
| 650 | 0 | |a Pharmacokinetics. | |
| 650 | 1 | 2 | |a Drug Monitoring |x methods |0 (DNLM)D016903Q000379 |
| 650 | 2 | 2 | |a Pharmaceutical Preparations |x standards |0 (DNLM)D004364Q000592 |
| 650 | 2 | |a Drug Therapy |0 (DNLM)D004358 | |
| 650 | 2 | |a Biomarkers |0 (DNLM)D015415 | |
| 650 | 2 | |a Biological Monitoring |0 (DNLM)D000079687 | |
| 650 | 2 | |a Pharmacokinetics |0 (DNLM)D010599 | |
| 650 | 6 | |a Pharmacovigilance. |0 (CaQQLa)201-0217159 | |
| 650 | 6 | |a Chimioth�erapie. |0 (CaQQLa)201-0034750 | |
| 650 | 6 | |a Marqueurs biologiques. |0 (CaQQLa)201-0177920 | |
| 650 | 6 | |a Surveillance biologique. |0 (CaQQLa)201-0025836 | |
| 650 | 6 | |a M�edicaments |x Analyse. |0 (CaQQLa)201-0036381 | |
| 650 | 6 | |a Pharmacocin�etique. |0 (CaQQLa)201-0070307 | |
| 650 | 7 | |a environmental monitoring. |2 aat |0 (CStmoGRI)aat300379380 | |
| 650 | 7 | |a MEDICAL |x Chemotherapy. |2 bisacsh | |
| 650 | 7 | |a Biochemical markers |2 fast |0 (OCoLC)fst00831950 | |
| 650 | 7 | |a Biological monitoring |2 fast |0 (OCoLC)fst00832280 | |
| 650 | 7 | |a Chemotherapy |2 fast |0 (OCoLC)fst00853595 | |
| 650 | 7 | |a Drug monitoring |2 fast |0 (OCoLC)fst00898688 | |
| 650 | 7 | |a Drugs |x Analysis |2 fast |0 (OCoLC)fst00898769 | |
| 650 | 7 | |a Pharmacokinetics |2 fast |0 (OCoLC)fst01060250 | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Dasgupta, Amitava, |d 1958- | |
| 776 | 0 | 8 | |i Print version: |a Dasgupta, Amitava. |t Therapeutic Drug Monitoring : Newer Drugs and Biomarkers. |d Burlington : Elsevier Science, �2012 |z 9780123854674 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780123854674 |z Texto completo |